-
181
Amino Functionalized Micro-Mesoporous Hybrid Particles for the Sustained Release of the Antiretroviral Drug Tenofovir
Published 2020-08-01“…Hybrid micro-mesoporous particles have been synthesized and functionalized with a silane coupling agent followed by loading the antiretroviral tenofovir. It has been observed that the disposition of the silane molecule on the surface of the particles determines the interaction mechanism with the antiretroviral molecule loaded independently on the surface area of the particles. …”
Get full text
Article -
182
Modelling tenofovir release kinetics from hyaluronidase-sensitive nanomedicine: A deterministic approach
Published 2023-09-01“…The model analysis conducted with tenofovir loaded hyaluronidase sensitive NM clearly shows the α factor significantly increased with triggering stimuli due to its enzymatic action on its substrate (hyaluronic acid). …”
Get full text
Article -
183
Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B
Published 2020-10-01Get full text
Article -
184
Virological profiles of hepatitis B virus (HBV)-infected African patients treated with tenofovir
Published 2014-04-01Get full text
Article -
185
Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS
Published 2015-08-01“…Roberta Prinapori,1 Antonio Di Biagio2 1Infectious Diseases, University of Genoa, Genoa, Italy; 2Unit of Infectious Diseases, IRCCS AOU San Martino-IST, Genoa, Italy Abstract: The fixed-dose combination (FDC) elvitegravir/cobicistat/emtricitabine/tenofovir (EVG/c/FTC/TDF) is a once-daily, single-tablet regimen containing an integrase strand transfer inhibitor and a pharmacoenhancer (cobicistat) associated with two nucleos(t)ide reverse transcriptase inhibitors. …”
Get full text
Article -
186
New simple spectrophotometric method for determination of the antiviral mixture of emtricitabine and tenofovir disoproxil fumarate
Published 2017-05-01Subjects: Get full text
Article -
187
Acute Trigeminal Neuralgia Associated with Initiation of Emtricitabine/Tenofovir for HIV Pre-Exposure Prophylaxis
Published 2018-03-01“…HIV pre-exposure prophylaxis (PrEP) with emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) fixed-dose combination (FTC/TDF) is undergoing rapid scale-up in the United States. …”
Get full text
Article -
188
The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity.
Published 2012-01-01“…Tenofovir has been associated with renal phosphate wasting, reduced bone mineral density, and higher parathyroid hormone levels. …”
Get full text
Article -
189
Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B
Published 2024-02-01Subjects: Get full text
Article -
190
The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2
Published 2022-06-01Subjects: Get full text
Article -
191
Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 Prevention
Published 2014-12-01Subjects: “…tenofovir…”
Get full text
Article -
192
Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure
Published 2021-01-01Subjects: Get full text
Article -
193
Evaluation of the Efficacy of Entecavir and Tenofovir in the Treatment of Chronic Hepatitis B: A Retrospective Study
Published 2019-12-01Subjects: Get full text
Article -
194
Mitotherapy inhibits against tenofovir induced nephrotoxicity on rat renal proximal tubular cells
Published 2024-07-01Subjects: “…Tenofovir…”
Get full text
Article -
195
Tribute to John C. Martin at the Twentieth Anniversary of the Breakthrough of Tenofovir in the Treatment of HIV Infections
Published 2021-12-01Subjects: Get full text
Article -
196
Chronic Hepatitis B Relapse Rates after Cessation of Tenofovir Alafenamide and Entecavir Therapy
Published 2023-03-01Subjects: Get full text
Article -
197
Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females
Published 2012-07-01“…This article reviews the currently available data for tenofovir as an anti-herpes agent, as well as unanswered questions about delivery systems, drug formulation, rectal administration, drug resistance, and clinical applications.Keywords: tenofovir, herpes simplex virus type 2, microbicide, CAPRISA-004…”
Get full text
Article -
198
Serum cytokine profiles and chronic hepatitis B patients discontinuing entecavir or tenofovir therapy
Published 2024-02-01Get full text
Article -
199
Case of Pregnant Hepatitis B Presenting with Hepatic Exacerbation After Cessation of Tenofovir Treatment
Published 2017-12-01Subjects: Get full text
Article -
200
The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic Review
Published 2024-01-01“…This study aims to review evidence of the cost-effectiveness of DTG in combination with tenofovir and lamivudine compared with the standard of care for HIV therapy. …”
Get full text
Article